FDA inspection
Janssen Alzheimer Immunotherapy: FDA inspection ending Nov 9, 2012
FDA inspection 806884 · No Action Indicated (NAI) · South San Francisco, CA
Key facts
| Inspection ID | 806884 |
|---|---|
| Firm | Janssen Alzheimer Immunotherapy |
| FEI number | 3009064743 |
| Address | 700 Gateway Blvd |
| City | South San Francisco |
| State | CA |
| ZIP | 94080 |
| Country | United States |
| Fiscal year | 2013 |
| Inspection end date | Nov 9, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data